CVM and NWBO may be deliberately withholding topline data now, IMO. CVM says waiting for full data analyses and NWBO says waiting decision to publish at a Reputed Journal, I have never heard that kind of reason from a small biotech company, thanks for your help.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.